Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
- Status
- COMPLETED
- Phase
- PHASE2
Epigenetic Changes in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes
- Status
- COMPLETED
- Phase
- NA
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Ribociclib and Spartalizumab in R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)
- Status
- COMPLETED
- Phase
- PHASE3
18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
- Status
- UNKNOWN
- Phase
- NA
A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
- Status
- COMPLETED
- Phase
- PHASE1
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- NA